天臣医疗
(688013)
| 流通市值：13.30亿 | | | 总市值：13.30亿 |
| 流通股本：8115.56万 | | | 总股本：8115.56万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 60,219,598.04 | 253,645,801.13 | 181,700,399.51 | 127,492,733.63 |
| 营业收入 | 60,219,598.04 | 253,645,801.13 | 181,700,399.51 | 127,492,733.63 |
| 二、营业总成本 | 48,519,815.97 | 217,294,809.52 | 153,771,750.31 | 104,452,301.51 |
| 营业成本 | 24,967,615.12 | 111,367,927.97 | 78,366,555.42 | 53,996,660.29 |
| 税金及附加 | 583,020.94 | 3,199,052.97 | 2,006,439.5 | 1,457,796.51 |
| 销售费用 | 9,008,408.12 | 41,608,582.67 | 28,145,468.65 | 18,353,183.65 |
| 管理费用 | 7,580,158.38 | 30,541,923.94 | 22,616,188.21 | 16,012,762.3 |
| 研发费用 | 7,098,705.62 | 35,319,802.67 | 24,686,254.99 | 16,704,767.78 |
| 财务费用 | -718,092.21 | -4,742,480.7 | -2,049,156.46 | -2,072,869.02 |
| 其中:利息费用 | 21,867.95 | 85,991.6 | 65,506.63 | 38,499.45 |
| 其中:利息收入 | 1,231,398.33 | 2,468,005.61 | 1,323,026.85 | 154,309.03 |
| 加:公允价值变动收益 | -749,305.66 | 4,056,148.9 | 2,861,376.47 | 1,701,887.64 |
| 加:投资收益 | 1,099,630.17 | 5,564,978.07 | 4,582,656.72 | 3,939,063.96 |
| 资产处置收益 | - | 1,570.92 | 2,528.78 | 2,528.78 |
| 资产减值损失(新) | -118,294.84 | -174,753.65 | -370,694.79 | -594,700.87 |
| 信用减值损失(新) | 212,988.51 | -310,994.8 | 63,276.34 | 146,886.63 |
| 其他收益 | 351,419.37 | 946,373.18 | 389,350.55 | 152,783.39 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 12,496,219.62 | 46,434,314.23 | 35,457,143.27 | 28,388,881.65 |
| 加:营业外收入 | 25,000 | 2,022,757 | 641,439.76 | 612,471.25 |
| 减:营业外支出 | 160,000 | 509,798.18 | 160,319.36 | 160,311.69 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 12,361,219.62 | 47,947,273.05 | 35,938,263.67 | 28,841,041.21 |
| 减:所得税费用 | 1,009,214.25 | 636,053.85 | 2,826,399.29 | 2,251,489.06 |
| 六、净利润 | 11,352,005.37 | 47,311,219.2 | 33,111,864.38 | 26,589,552.15 |
| 持续经营净利润 | 11,352,005.37 | 47,311,219.2 | 33,111,864.38 | 26,589,552.15 |
| 归属于母公司股东的净利润 | 11,352,005.37 | 47,311,219.2 | 33,111,864.38 | 26,589,552.15 |
| (一)基本每股收益 | 0.14 | 0.6 | 0.41 | 0.33 |
| (二)稀释每股收益 | 0.14 | 0.58 | 0.4 | 0.33 |
| 八、其他综合收益 | 50,456.82 | -169,910.82 | -59,296.28 | -174,147.44 |
| 归属于母公司股东的其他综合收益 | 50,456.82 | -169,910.82 | -59,296.28 | -174,147.44 |
| 九、综合收益总额 | 11,402,462.19 | 47,141,308.38 | 33,052,568.1 | 26,415,404.71 |
| 归属于母公司股东的综合收益总额 | 11,402,462.19 | 47,141,308.38 | 33,052,568.1 | 26,415,404.71 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |